COMPANY
Clinical Phase 2
Keywords: neurology neurodegenerative disease Aicardi-Goutières Syndrome Progressive Supranuclear Palsy Amyotrophic Lateral Sclerosis Frontotemporal Dementia TPN-101
Location: San Diego, CA · source · Oct 15, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 2: TPN-101 in Aicardi-Goutières Syndrome (AGS) source ↗
- Trial start 2: A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) source ↗
- Trial start 2: A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD source ↗
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT05613868 | TPN-101 in Aicardi-Goutières Syndrome (AGS) | Phase 2 | Terminated | Mar 15, 2023 | Feb 27, 2025 (actual) |
| NCT04993768 | A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) | 2 | Completed | Dec 12, 2021 | Feb 24, 2024 (actual) |
| NCT04993755 | A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD | 2 | Completed | Oct 1, 2021 | Aug 17, 2023 (actual) |
